Capabilities

• Meta Platforms has acquired Manus, a Singapore-based AI startup, in a $2 billion deal announced on May 7, 2026, focusing on autonomous agents that plan and execute complex tasks. • Manus specializes in agentic AI technology, enabling systems to independently handle multi-step processes without constant human oversight. • The acquisition positions Meta to expand its AI portfolio amid intensifying competition in generative and autonomous AI development globally.

• AcuityMD announced $80 million in new funding to advance its platform with sophisticated AI features for medical device insights. • The investment accelerates AI integration to improve market intelligence for US healthcare and medtech firms. • This capital infusion positions AcuityMD to dominate AI-powered analytics in the growing $500B+ medical device sector.

• OpenAI unveiled GPT-5 on April 19, featuring advanced multimodal reasoning that processes text, images, and audio simultaneously with a 40% performance improvement over GPT-4, according to the company's research blog. • The model demonstrates enhanced chain-of-thought reasoning and can solve complex multi-step problems across domains including mathematics, coding, and scientific analysis with significantly higher accuracy rates. • Industry analysts project GPT-5 will accelerate enterprise AI adoption and intensify competition with Anthropic's Claude and Google's Gemini in the large language model market.